↓ Skip to main content

The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia

Overview of attention for article published in American Journal of Cardiovascular Drugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
9 patents
googleplus
1 Google+ user

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
46 Mendeley
Title
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia
Published in
American Journal of Cardiovascular Drugs, August 2012
DOI 10.2165/11590330-000000000-00000
Pubmed ID
Authors

Michel Farnier

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Netherlands 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Student > Bachelor 8 17%
Student > Ph. D. Student 7 15%
Student > Master 5 11%
Other 4 9%
Other 10 22%
Unknown 4 9%
Readers by discipline Count As %
Medicine and Dentistry 12 26%
Agricultural and Biological Sciences 9 20%
Biochemistry, Genetics and Molecular Biology 8 17%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Philosophy 1 2%
Other 2 4%
Unknown 9 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#4,836,328
of 25,374,917 outputs
Outputs from American Journal of Cardiovascular Drugs
#99
of 467 outputs
Outputs of similar age
#33,570
of 187,105 outputs
Outputs of similar age from American Journal of Cardiovascular Drugs
#19
of 127 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 467 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.